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SURGICAL ETHICS CHALLENGES
What to tell patients harmed by other physicians
James W. Jones, MD, PhD, MHA,a Laurence B. McCullough, PhD,b and Bruce W. Richman, MA,c
Columbia, Mo; and Houston, Tex
A 60-year-old obese diabetic woman with a history of
CABG underwent a successful right femorodistal non-
reversed vein graft salvage procedure 6 years ago. She
has done well since, and has been compliant with an
antiplatelet medication regimen. She had a laparoscopic
cholecystectomy done yesterday at another local hospi-
tal. Her antiplatelet drugs were held, and someone
tried to start a femoral arterial line on the grafted side.
She was transferred to your care at the university med-
ical center the same afternoon with a painful avascular
right leg. While operating, you find that the badly
damaged proximal graft has thrombosed and you are
unable to re-establish blood flow to the leg. The rest of
the observable graft appears pristine. An amputation is
going to be required, and the family wants to know
what happened. What should you do?
A. Advise them that you believe the other surgeon caused
the catastrophe.
B. Tell them that the graft was worn out and probably
would have failed soon.
C. Tell them nothing.
D. Respond fully to the family after discussing his case
management with the surgeon who performed the
cholecystectomy.
E. Notify the patient, their family, the chief of surgery at the
other hospital, and the state medical board.
In an era of medical specialization, complications of
one physician’s therapy often must be managed by another.
Nonsurgical specialties regularly refer major anatomic com-
plications to surgeons, and, correspondingly, vascular sur-
geons often depend on nephrologists, neurologists, cardi-
ologists, gastroenterologists, radiologists, pulmonologists,
and others to resolve postoperative complications. In the
practice of technologically advanced medicine, cooperation
among specialties is essential to resolution of complex
complications associated with another physician’s clinical
management. In such an environment, the complex tangle
of informed consent, self-protection, an abundance of
opinions about what should have been done, the guild
mentality, and multiple simultaneous patient-physician re-
lationships can create an atmosphere rife with conflict.
What should a consultant physician reveal about another
physician’s clinical errors and their sometimes terrible con-
sequences?
The Council on Ethical and Judicial Affairs (CEJA) of
the American Medical Association recommends full disclo-
sure when medical errors injure patients:
Patients have a right to know their past and present
medical status and to be free of any mistaken beliefs
concerning their conditions. Situations occasionally occur
in which a patient suffers from the physician’s mistake or
judgment. In these situations, the physician is ethically
required to inform the patient of all the facts necessary to
insure understanding of what has occurred. Only through
full disclosure is a patient able to make informed decisions
regarding future medical care.1
The goal of full disclosure is for the patient to understand
the nature and basis of her surgeon’s clinical judgment
about her condition and the plan to address it. As Brody
puts it, disclosure of information by the physician in the
informed consent should be transparent.2 The informed
consent process obligates the physician to explain to the
patient or family the nature of her condition, the medically
reasonable and available therapies, and the benefits and
risks associated with each option, including noninterven-
tion.3,4 Discussion of this patient’s condition should in-
clude an account of its etiology. If medical/surgical man-
agement was part of the etiology of the current ailment,
then the patient and family should be so advised, but
transparency in this case is best achieved by first consulting
the patient’s previous surgeon to determine what he be-
lieves occurred and why.
As the surgical specialist who has been asked to resolve
the complication and explain it to the family, you should
determine whether the lamentable outcome followed the
first surgeon’s medically reasonable treatment or was the
result of a departure from the accepted standard of care.
“Medically reasonable” means that a properly implemented
method of treatment can be reliably expected to produce
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more benefit than harm to the patient. Medically reason-
able care is beneficence-based, in the jargon of bioethics.5
“Reliably expected” means that the general surgeon had
some evidentiary basis, beyond his opinion, for a belief that
the treatment would benefit the patient. When established
treatment methods are available, a departure from the
standard of care violates both evidence-based and benefi-
cence-based obligations to the patient, precisely because no
physician could reasonably expect the treatment to produce
clinical benefit.
The availability of evidence can of course broaden or
narrow the range of reasonable treatments for a given
condition. In this case, therefore, the central ethical test
revolves around the question of whether preoperative dis-
continuation of antiplatelet therapy and siting the femoral
line on the same side as the graft were medically reasonable.
Judgments on these matters shape the remaining ethical
questions about how the case management should be ex-
plained to the patient and her family.
Briefly discontinuing the antiplatelet medication before
surgery slightly increases the risk to graft patency, but most
physicians would agree that this should be done to control
intraoperative blood loss. A femoral arterial line at the site
of an arterial graft is problematic. Was an arterial line even
necessary? If so, why was it not sited in a less vulnerable
extremity? You determined that damage from the at-
tempted femoral line caused the graft failure, and will
probably result in loss of the limb. Was the offending
procedure justifiable?
This case has the earmarks of a serious error in judg-
ment, but surgical judgment is heavily context dependent.
What, when, and how well an individual intervention is
made have everything to do with its result. Exploration of
such contexts is typically the subject of inquiry in divisional
Death and Complications conferences, and they provide a
structured arena for open discussion and criticism within an
institution’s surgical department. In this case, however,
your practice is located in a separate tertiary care hospital, so
combined case analysis in a D & C conference is not likely
to happen. You should nevertheless make an effort to
contact the other surgeon to discuss your concerns and
hear his sense of the context in which events occurred
before making a judgment as to their reasonableness. You
are ethically bound to notify and educate him to prevent
similar future problems. You could invite him to join you in
meeting with the family to discuss how the case was han-
dled, but you are the patient’s current moral agent and, as
such, bear responsibility for truth telling. Option D would
therefore be our first choice in responding to the family’s
request.
Option A is precipitous and deprives the general sur-
geon of an opportunity to explain his reasoning and intent.
Option B is intentionally misleading and violates the
patient’s unqualified right not to be deceived.6
Option C is similarly indefensible, because it denies the
patient her right to the truth about her care, the ethical
underpinning of the concept of informed consent.
Option E is premature and excessive, and because of
the responses initiated may place you and/or the other
physicians in an embarrassing unfair position.
The medical fraternity has historically protected itself
against disclosure of its errors and poor judgment, and the
habit persists, to the detriment of our professional integrity.
CEJA’s guidance is a significant corrective to this regretta-
ble tradition.
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